Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy · Delayed Price · Currency is EUR 52.70
+0.20 (0.38%)
Aug 17, 2026, 11:37 AM CET
BIT:REC Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,705 | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 | |
Revenue Growth | 9.10% | 11.82% | 12.45% | 12.36% | 17.29% | 9.06% |
Cost of Revenue | 771.62 | 763.94 | 703.78 | 600.76 | 516.93 | 427.73 |
Gross Profit | 1,934 | 1,854 | 1,638 | 1,482 | 1,336 | 1,152 |
Selling, General & Admin | 753.34 | 727.36 | 654.76 | 601.51 | 572.3 | 481.01 |
Research & Development | 352.89 | 340.95 | 286.03 | 255.75 | 220.1 | 166.14 |
Other Operating Expenses | 3.14 | 1.89 | -1.37 | -2.25 | -0.5 | 0.65 |
Operating Expenses | 1,109 | 1,070 | 939.42 | 855.01 | 791.91 | 647.8 |
Operating Income | 824.34 | 784.25 | 698.36 | 626.56 | 544.47 | 504.55 |
Interest Expense | -97.39 | -98.92 | -81.16 | -74.46 | -34.45 | -20.9 |
Interest & Investment Income | 0.07 | 0.07 | 5.96 | 4.18 | - | - |
Currency Exchange Gain (Loss) | 3.3 | 14.98 | -9.34 | 2.16 | -5.8 | -5.82 |
EBT Excluding Unusual Items | 730.32 | 700.38 | 613.82 | 558.44 | 504.22 | 477.83 |
Merger & Restructuring Charges | -27.77 | -88.82 | -45.43 | -67.95 | -93.47 | -11.73 |
Asset Writedown | -9.73 | -9.73 | -14.33 | -0.37 | -10.93 | -0.05 |
Other Unusual Items | -33.99 | -20.55 | -6.87 | 0.91 | 1.62 | -2.69 |
Pretax Income | 658.83 | 581.27 | 547.18 | 491.04 | 401.44 | 463.35 |
Income Tax Expense | 161.65 | 137.65 | 130.68 | 101.82 | 89.1 | 77.38 |
Earnings From Continuing Operations | 497.18 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Net Income | 497.18 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Net Income to Common | 497.18 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Net Income Growth | 22.08% | 6.51% | 7.01% | 24.61% | -19.08% | 8.73% |
Shares Outstanding (Basic) | 204 | 205 | 206 | 206 | 206 | 206 |
Shares Outstanding (Diluted) | 209 | 209 | 209 | 209 | 209 | 209 |
Shares Change | -0.14% | - | -0.01% | 0.04% | -0.01% | 0.01% |
EPS (Basic) | 2.43 | 2.16 | 2.02 | 1.89 | 1.52 | 1.87 |
EPS (Diluted) | 2.38 | 2.12 | 1.99 | 1.86 | 1.49 | 1.85 |
EPS Growth | 22.23% | 6.48% | 7.04% | 24.57% | -19.07% | 8.72% |
Free Cash Flow | 599.86 | 557.45 | 533.27 | 455.63 | 437.8 | 469.8 |
Free Cash Flow Per Share | 2.87 | 2.67 | 2.55 | 2.18 | 2.09 | 2.25 |
Dividend Per Share | 0.710 | 1.340 | 1.270 | 1.200 | 1.150 | 1.100 |
Dividend Growth | -45.38% | 5.51% | 5.83% | 4.35% | 4.54% | 4.76% |
Gross Margin | 71.48% | 70.82% | 69.94% | 71.15% | 72.11% | 72.93% |
Operating Margin | 30.47% | 29.95% | 29.83% | 30.09% | 29.38% | 31.93% |
Profit Margin | 18.38% | 16.94% | 17.79% | 18.69% | 16.85% | 24.43% |
Free Cash Flow Margin | 22.17% | 21.29% | 22.77% | 21.88% | 23.62% | 29.73% |
EBITDA | 1,014 | 977.05 | 852.08 | 757.12 | 659.21 | 592.2 |
EBITDA Margin | 37.49% | 37.31% | 36.39% | 36.36% | 35.57% | 37.48% |
D&A For EBITDA | 189.78 | 192.8 | 153.72 | 130.56 | 114.73 | 87.65 |
EBIT | 824.34 | 784.25 | 698.36 | 626.56 | 544.47 | 504.55 |
EBIT Margin | 30.47% | 29.95% | 29.83% | 30.09% | 29.38% | 31.93% |
Effective Tax Rate | 24.54% | 23.68% | 23.88% | 20.74% | 22.20% | 16.70% |